Side by Side

Compare

Read two to four stocks on the same scale — return, valuation and volatility in one table.

SelectedToday5Y Return

JAGXJaguar Health Inc− 14.06%− 100.00%
GTBPGT Biopharma Inc− 4.52%− 99.90%
AARDAardvark Therapeutics Inc− 6.11%− 59.55%
Partial Period · Feb 10, 2025 — Aug 31, 2026
CLNNClene Inc− 3.63%− 97.45%

Four symbols is the limit; remove one to add another.

Period Return

Each series is converted to a percentage of its own starting point, so all of them begin at zero. What is compared is the return over the period, not price levels.

JAGX− 100.0%GTBP− 99.9%AARD− 59.5%CLNN− 97.5%Tap or hover the chart for values along the way

Metric	JAGXJaguar Health Inc	GTBPGT Biopharma Inc	AARDAardvark Therapeutics Inc	CLNNClene Inc
Return
Last Price	0.60	0.24	5.38	3.85
Daily Change	− 14.06%	− 4.52%	− 6.11%	− 3.63%
Period ReturnPast 5 Years	− 100.00%	− 99.90%	− 59.55%Feb 10, 2025 — Aug 31, 2026	− 97.45%
Valuation
Market Cap	$2.93 M	$10.7 M	$118 M	$49.2 M
P/E Ratio	—	1.99	—	—
Dividend Yield	—	—	—	—
Net MarginTrailing 12M	130.9%	26,209.5%	—	20,059.9%
Risk
Beta	-0.24	0.85	3.78	1.05
52-Week Range	0.69 — $85.40	0.25 — $1.37	3.35 — $17.94	3.75 — $13.50
Company
Sector	—	—	—	—
Industry	Pharmaceuticals	Biotechnology	Pharmaceuticals	Biotechnology

Company

JAGXPharmaceuticals
GTBPBiotechnology
AARDPharmaceuticals
CLNNBiotechnology

FinnhubUpdated 23:00

To Understand This

P/E and the Valuation RatiosYou can't tell whether a stock is cheap or expensive by looking at its price.Diversification: How Many Baskets Are Enough?Owning ten different stocks is not the same as owning ten different risks.